Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells

Fluids and Barriers of the CNS

Volumn 10, Issue 1, 2013, Pages

  Haqqani, Arsalan S ^a   Delaney, Christie E ^a   Tremblay, Tammy Lynn ^a   Sodja, Caroline ^a   Sandhu, Jagdeep K ^a   Stanimirovic, Danica B ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Biomarkers; Blood brain barrier; CNS; Drug delivery; Endothelial cells; Exosomes; Mass spectrometry; Microvesicles; Proteomics; Receptor mediated transcytosis

Indexed keywords

ALIX PROTEIN; BIOLOGICAL MARKER; CD81 ANTIGEN; CD9 ANTIGEN; INSULIN RECEPTOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEIN; TETRASPANIN; TRANSFERRIN RECEPTOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN ENDOTHELIUM CELL; CELL ISOLATION; CELL VACUOLE; ENDOTHELIUM CELL; EXOSOME; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS;

EID: 84873438103     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/2045-8118-10-4     Document Type: Article

References (39)

1. Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res 2003, 61:39-78.
2. Pardridge WM, Buciak JL, Friden PM. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. J Pharmacol Exp Ther 1991, 259:66-70.
3. Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, Atwal J, Elliott JM, Prabhu S, Watts RJ, Dennis MS. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med 2011, 3:84ra44. 10.1126/scitranslmed.3002230, 21613623.
4. Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, Pardridge WM. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharm Res 2000, 17:266-274. 10.1023/A:1007592720793, 10801214.
5. Boado RJ, Hui EK, Lu JZ, Zhou QH, Pardridge WM. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein. J Biotechnol 2010, 146:84-91. 10.1016/j.jbiotec.2010.01.011, 2832096, 20100527.
6. Demeule M, Currie JC, Bertrand Y, Che C, Nguyen T, Regina A, Gabathuler R, Castaigne JP, Beliveau R. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008, 106:1534-1544. 10.1111/j.1471-4159.2008.05492.x, 18489712.
7. Gabathuler R. Development of new peptide vectors for the transport of therapeutic across the blood-brain barrier. Ther Deliv 2010, 1:571-586. 10.4155/tde.10.35, 22833968.
8. Ohshima-Hosoyama S, Hosoyama T, Nelon LD, Keller C. IGF-1 receptor inhibition by picropodophyllin in medulloblastoma. Biochem Biophys Res Commun 2010, 399:727-732. 10.1016/j.bbrc.2010.08.009, 20692232.
9. Yang C, Robbins PD. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011, 2011:842849. 3235485, 22190973.
10. Thery C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep 2011, 3:15. 3155154, 21876726.
11. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19:43-51. 10.1016/j.tcb.2008.11.003, 19144520.
12. Pant S, Hilton H, Burczynski ME. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol 2012, 83:1484-1494. 10.1016/j.bcp.2011.12.037, 22230477.
13. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 2006, 3:22. 10.1002/0471143030.cb0322s30, 18228490.
14. Simpson RJ, Jensen SS, Lim JW. Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8:4083-4099. 10.1002/pmic.200800109, 18780348.
15. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins. RNA and lipids. Nucleic Acids Res 2012, 40:D1241-D1244.
16. Smalheiser NR. Do Neural Cells Communicate with Endothelial Cells via Secretory Exosomes and Microvesicles?. Cardiovasc Psychiatry Neurol 2009, 2009:383086. 2790149, 20029619.
17. Vella LJ, Sharples RA, Nisbet RM, Cappai R, Hill AF. The role of exosomes in the processing of proteins associated with neurodegenerative diseases. Eur Biophys J 2008, 37:323-332. 10.1007/s00249-007-0246-z, 18064447.
18. Segura E, Amigorena S, Thery C. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis 2005, 35:89-93. 10.1016/j.bcmd.2005.05.003, 15990342.
19. Liu ML, Williams KJ. Microvesicles: potential markers and mediators of endothelial dysfunction. Curr Opin Endocrinol Diabetes Obes 2012, 19:121-127.
20. Virgintino D, Rizzi M, Errede M, Strippoli M, Girolamo F, Bertossi M, Roncali L. Plasma membrane-derived microvesicles released from tip endothelial cells during vascular sprouting. Angiogenesis 2012, 15:761-769. 10.1007/s10456-012-9292-y, 3496552, 22886085.
21. Clayton A, Mason MD. Exosomes in tumour immunity. Curr Oncol 2009, 16:46-49. 2695711, 19526085.
22. Chivet M, Hemming F, Pernet-Gallay K, Fraboulet S, Sadoul R. Emerging role of neuronal exosomes in the central nervous system. Front Physiol 2012, 3:145. 3361079, 22654762.
23. Lachenal G, Pernet-Gallay K, Chivet M, Hemming FJ, Belly A, Bodon G, Blot B, Haase G, Goldberg Y, Sadoul R. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol Cell Neurosci 2011, 46:409-418. 10.1016/j.mcn.2010.11.004, 21111824.
24. Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
25. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009, 6:359-362. 10.1038/nmeth.1322, 19377485.
26. Hirosawa M, Hoshida M, Ishikawa M, Toya T. MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci 1993, 9:161-167.
27. Haqqani AS, Kelly JF, Stanimirovic DB. Quantitative protein profiling by mass spectrometry using label-free proteomics. Methods Mol Biol 2008, 439:241-256. 10.1007/978-1-59745-188-8_17, 18370108.
28. Haqqani AS, Caram-Salas N, Ding W, Brunette E, Delaney CE, Baumann E, Boileau E, Stanimirovic DB. Multiplexed evaluation of serum and CSF pharmacokinetics of brain-targeting single-domain antibodies using nanoLC-SRM-ILIS method. Mol Pharm 2012, In Press.
29. Haqqani AS, Stanimirovic DB. Intercellular interactomics of human brain endothelial cells and th17 lymphocytes: a novel strategy for identifying therapeutic targets of CNS inflammation. Cardiovasc Psychiatry Neurol 2011, 2011:175364. 3130966, 21755032.
30. Yu LR, Conrads TP, Uo T, Kinoshita Y, Morrison RS, Lucas DA, Chan KC, Blonder J, Issaq HJ, Veenstra TD. Global analysis of the cortical neuron proteome. Mol Cell Proteomics 2004, 3:896-907. 10.1074/mcp.M400034-MCP200, 15231876.
31. Abulrob A, Sprong H, Van Bergen en HP, Stanimirovic D. The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells. J Neurochem 2005, 95:1201-1214. 10.1111/j.1471-4159.2005.03463.x, 16271053.
32. Muruganandam A, Tanha J, Narang S, Stanimirovic D. Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J 2002, 16:240-242.
33. Tanha J, Muruganandam A, Stanimirovic D. Phage display technology for identifying specific antigens on brain endothelial cells. Methods Mol Med 2003, 89:435-449.
34. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
35. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29:341-345. 10.1038/nbt.1807, 21423189.
36. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, Ju S, Mu J, Zhang L, Steinman L, Miller D, Zhang HG. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 2011, 19:1769-1779. 10.1038/mt.2011.164, 3188748, 21915101.
37. Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007, 24:1759-1771. 10.1007/s11095-007-9379-0, 2685177, 17619996.
38. Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997, 138:877-889. 10.1083/jcb.138.4.877, 2138047, 9265653.
39. Demeule M, Poirier J, Jodoin J, Bertrand Y, Desrosiers RR, Dagenais C, Nguyen T, Lanthier J, Gabathuler R, Kennard M, Jefferies WA, Karkan D, Tsai S, Fenart L, Cecchelli R, Beliveau R. High transcytosis of melanotransferrin (P97) across the blood-brain barrier. J Neurochem 2002, 83:924-933. 10.1046/j.1471-4159.2002.01201.x, 12421365.